Concord Drugs Ltd

Concord_Drugs06 Dec 2024

Pharmaceuticals

₹

-0.15 (-0.39%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Concord Drugs Ltd

Concord Drugs Ltd

Pharmaceuticals

Concord_Drugs06 Dec 2024

₹

-0.15 (-0.39%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-Nov-2024	BC	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Un-audited Financials for quarter ended 30th	13-Nov-2024
18-Sep-2024	BC	AGM 30/09/2024 Voting Results and Scrutinizers Report of 29th AGM FY 2023-2024. (As Per BSE Announcement Dated on: 01/10/2024)	30-Sep-2024
18-Sep-2024	BC	Annual General Meeting	24-Sep-2024
02-Sep-2024	BC	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve Increase in Authorized Capital Proposal for I	06-Sep-2024
03-Aug-2024	BC	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Concord Drugs Ltd has informed BSE that the m	09-Aug-2024

No Rights has been declared by Concord_Drugs

Book Closure

Record Date	Split Date	Purpose
13-Nov-2024	-	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Un-audited Financials for quarter ended 30th
30-Sep-2024	-	AGM 30/09/2024 Voting Results and Scrutinizers Report of 29th AGM FY 2023-2024. (As Per BSE Announcement Dated on: 01/10/2024)
24-Sep-2024	01 Jan'1900	Annual General Meeting
06-Sep-2024	-	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve Increase in Authorized Capital Proposal for I
09-Aug-2024	-	Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Concord Drugs Ltd has informed BSE that the m

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Concord Drugs Ltd ₹37.86(-0.15/-0.39%)	37.86	-0.15	37.86	5.34	0.00	1.12
Ambalal Sarabhai Enterprises Ltd ₹58.37(+0.38/0.66%)	58.37	+0.38	447.31	43.06	50.76	9.93
Astrazeneca Pharma India Ltd ₹6,632.55(+2.00/0.03%)	6,632.55	+2.00	16,581.38	37.91	128.81	24.41
Abbott India Ltd ₹29,053.50(+29.75/0.10%)	29,053.50	+29.75	61,738.69	25.91	48.06	17.53
Amrutanjan Health Care Ltd ₹722.80(-15.20/-2.06%)	722.80	-15.20	2,089.66	21.23	43.97	7.02
Bliss GVS Pharma Ltd ₹157.90(-2.90/-1.80%)	157.90	-2.90	1,663.19	18.28	20.59	1.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	0.08	0.04	0.04	0.01	0.16
Net Cash from Operating Activities	1.96	2.24	0.77	1.62	2.48
Net Cash Used In Investing Activities	-1.21	-2.27	-2.44	-3.67	-0.84
Net Cash Used In Financing Activities	-0.69	0.05	1.68	2.07	-1.79
Net Inc./Dec In Cash And Cash Equivalents	0.06	0.03	0.01	0.02	-0.15
Cash And Cash Equivalents At End Of The Year	0.14	0.08	0.04	0.04	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.39%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

45.61%

**Promoter pledged shareholding 54.39%

About Concord Drugs Ltd

Concord Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 37.86 crores. It has reported a sales of Rs. 11.84 crores and a net profit of Rs. 0.05 crores for the quarter ended December 2018. The company management includes S Nagi Reddy, S Nagi Reddy,K Ramchandra Reddy,Koni Reddy,S. Nagavenkata Hareesh,S. Manoj Kumar Reddy,Summela Kasu,Namratha Nagla (Concord Drugs Ltd) among others.

Chairman

S Nagi Reddy

Registered office

Survey No 249 Brahmanapally V,Hayathnagar M,Ranga Reddy,Telangana,501511

FAX :

Background

Incorporation Year1995

Face Value₹10

Market Lot1